B

Bioatla Inc
NASDAQ:BCAB

Watchlist Manager
Bioatla Inc
NASDAQ:BCAB
Watchlist
Price: 0.724 USD 8.06% Market Closed
Market Cap: 42.6m USD

Wall Street
Price Targets

BCAB Price Targets Summary
Bioatla Inc

There are no price targets for BCAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bioatla Inc Competitors:
Price Targets
688180
Shanghai Junshi Biosciences Co Ltd
24% Downside
ENTA
Enanta Pharmaceuticals Inc
18% Upside
CMPX
Compass Therapeutics Inc.
144% Upside
4BB
4Basebio PLC
182% Upside
DTIL
Precision BioSciences Inc
673% Upside
ALXO
ALX Oncology Holdings Inc
125% Upside
300896
Imeik Technology Development Co Ltd
39% Upside
BVXP
Bioventix PLC
121% Upside

Revenue
Forecast

Revenue Estimate
Bioatla Inc

For the last 5 years the compound annual growth rate for Bioatla Inc's revenue is 16%.

16%
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-75%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioatla Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioatla Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCAB's stock price target?
Not Available

BCAB doesn't have any price targets made by Wall Street professionals.

Back to Top